Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,271 · see citing works

Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment

Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718 · see citing works

Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin

Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476 · see citing works

<i>Fusobacterium nucleatum</i> infection is prevalent in human colorectal carcinoma

Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043 · see citing works

Multitarget Stool DNA Testing for Colorectal-Cancer Screening

Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Levin, T. R., Lavin, P., Lidgard, G. P., Ahlquist, D. A., & Berger, B. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311194 · Cited by 1,900 · see citing works

Quality indicators for colonoscopy

Rex, D. K., Schoenfeld, P. S., Cohen, J., Pike, I. M., Adler, D. G., Fennerty, M. B., Lieb, J. G., Park, W. G., Rizk, M. K., Sawhney, M. S., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.07.058 · Cited by 1,764 · see citing works

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

Atkin, W. S., Edwards, R., Kralj‐Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M. A., Parkin, D. M., Wardle, J., Duffy, S. W., & Cuzick, J. M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60551-x · Cited by 1,618 · see citing works

Gut microbiome development along the colorectal adenoma-carcinoma sequence

Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., Zhang, D., Xia, H., Xu, X., Jie, Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms7528 · Cited by 1,506 · see citing works

American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008

Rex, D. K., Johnson, D. A., Anderson, J. C., Schoenfeld, P. S., Burke, C. A., & Inadomi, J. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.104 · Cited by 1,397 · see citing works

Potential of fecal microbiota for early-stage detection of colorectal cancer

Zeller, G., Tap, J., Voigt, A. Y., Sunagawa, S., Kultima, J. R., Costea, P. I., Amiot, A., Böhm, J., Brunetti, F., Habermann, N., et al. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145645 · Cited by 1,375 · see citing works

Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

Yu, J. Q., Feng, Q., Wong, S. H., Zhang, D., Liang, Q. Y., Qin, Y., Tang, L., Zhao, H., Stenvang, J., Li, Y., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309800 · Cited by 1,247 · see citing works

<i>Fusobacterium nucleatum</i> in colorectal carcinoma tissue and patient prognosis

Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310101 · Cited by 1,080 · see citing works

Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy

Schoen, R. E., Pinsky, P. F., Weissfeld, J. L., Yokochi, L. A., Church, T. R., Laiyemo, A. O., Bresalier, R. S., Andriole, G. L., Buys, S. S., Crawford, E. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114635 · Cited by 1,014 · see citing works

Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc

Abed, J., Emgård, J. E. M., Zamir, G., Faroja, M., Almogy, G., Grenov, A., Sol, A., Naor, R., Pikarsky, E., Atlan, K. A., et al. (2016) · Cell Host &amp; Microbe · doi:10.1016/j.chom.2016.07.006 · Cited by 888 · see citing works

Increasing incidence of colorectal cancer in Asia: implications for screening

Sung, J. J. �., Lau, J., Goh, K., & Leung, W. K. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70422-8 · Cited by 740 · see citing works

Accuracy of Fecal Immunochemical Tests for Colorectal Cancer

Lee, J. K., Liles, E. G., Bent, S., Levin, T. R., & Corley, D. A. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1484 · Cited by 707 · see citing works

Gut mucosal microbiome across stages of colorectal carcinogenesis

Nakatsu, G., Li, X., Zhou, H., Sheng, J., Wong, S. H., Wu, W. K. K., Ng, S. C., Tsoi, H., Dong, Y., Zhang, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms9727 · Cited by 701 · see citing works

The human gut microbiome as a screening tool for colorectal cancer

Zackular, J. P., Rogers, M. A. M., Ruffin, M. T., & Schloss, P. D. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0129 · Cited by 551 · see citing works

Fusobacterium Is Associated with Colorectal Adenomas

McCoy, A. N., Araújo-Pérez, F., Azcárate-Peril, M. A., Yeh, J. J., Sandler, R. S., & Keku, T. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053653 · Cited by 516 · see citing works

Quality indicators for colonoscopy

Rex, D. K., Petrini, J. L., Baron, T. H., Chak, A., Cohen, J., Deal, S. E., Hoffman, B. J., Jacobson, B. C., Mergener, K., Petersen, B. T., et al. (2006) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2006.02.021 · Cited by 494 · see citing works

An updated Asia Pacific Consensus Recommendations on colorectal cancer screening

Sung, J. J. �., Ng, S. C., Chan, F. K. L., Chiu, H., Kim, H. S., Matsuda, T., Ng, S. S. M., Lau, J. Y. W., Zheng, S. S., Adler, S. N., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306503 · Cited by 406 · see citing works

Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions

Baxter, N. T., Ruffin, M. T., Rogers, M. A. M., & Schloss, P. D. (2016) · Genome Medicine · doi:10.1186/s13073-016-0290-3 · Cited by 354 · see citing works

Comparative Evaluation of Immunochemical Fecal Occult Blood Tests for Colorectal Adenoma Detection

Hundt, S., Haug, U., & Brenner, H. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-3-200902030-00005 · Cited by 330 · see citing works

Screening for colorectal cancer in Chinese: Comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy

Sung, J. J. �., Chan, F. K. L., Leung, W. K., Wu, J. C., Lau, J. Y. W., Ching, J. Y. L., To, K. F., Lee, Y. T., Luk, Y. W., Kung, N. N. S., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50090 · Cited by 166 · see citing works

Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia

Ladabaum, U., & Mannalithara, A. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.003 · Cited by 165 · see citing works

Multitarget Stool DNA Testing for Colorectal-Cancer Screening

Brenner, H., Werner, S., & Chen, H. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1405215 · Cited by 164 · see citing works

Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma

Wu, C. W., Ng, S. C., Dong, Y., Tian, L., Ng, S. S. M., Leung, W. W., Law, W. T., Yau, T. O., Chan, F. K. L., Sung, J. J. Y., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1750 · Cited by 119 · see citing works

Colorectal cancer screening in Asia

Ng, S. S. S., & Wong, S. (2013) · British Medical Bulletin · doi:10.1093/bmb/lds040 · Cited by 106 · see citing works

Quantitative Immunochemical Fecal Occult Blood Testing for Colorectal Adenoma Detection: Evaluation in the Target Population of Screening and Comparison With Qualitative Tests

Haug, U., Hundt, S., & Brenner, H. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.668 · Cited by 98 · see citing works

Combining biomarkers to detect disease with application to prostate cancer

Etzioni, R. (2003) · Biostatistics · doi:10.1093/biostatistics/4.4.523 · Cited by 95 · see citing works

The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy

Wong, M. C. S., Ching, J. Y. L., Chan, V. C. W., & Sung, J. J. �. (2015) · Scientific Reports · doi:10.1038/srep13568 · Cited by 44 · see citing works

A standard for Faecal Immunochemical TesTs for Haemoglobin Evaluation Reporting (FITTER)

Fraser, C. G., Allison, J. E., Young, G. P., Halloran, S. P., & Seaman, H. E. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563213514392 · Cited by 31 · see citing works

Logistic regression analysis with standardized markers

Huang, Y., PEPE, M. S., & Feng, Z. (2013) · The Annals of Applied Statistics · doi:10.1214/13-aoas634 · Cited by 10 · see citing works

Gut microbiota in colorectal cancer: mechanisms of action and clinical applications

Wong, S. H., & Yu, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0209-8 · Cited by 1,355 · see citing works

A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis

Sawicki, T., Ruszkowska, M., Danielewicz, A., Niedźwiedzka, E., Arłukowicz, T., & Przybyłowicz, K. E. (2021) · Cancers · doi:10.3390/cancers13092025 · Cited by 1,017 · see citing works

Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer

Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752 · see citing works

Gut microbiota in colorectal cancer development and therapy

Wong, C. C., & Yu, J. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00766-x · Cited by 751 · see citing works

The Intestinal Microbiota and Colorectal Cancer

Cheng, Y., Ling, Z., & Li, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615056 · Cited by 588 · see citing works

Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers

Dai, Z., Coker, O. O., Nakatsu, G., Wu, W. K. K., Zhao, L., Chen, Z., Chan, F. K. L., Kristiansen, K., Sung, J. J. Y., Wong, S. H., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0451-2 · Cited by 545 · see citing works

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 440 · see citing works

Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer

Wang, N., & Fang, J. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.08.010 · Cited by 395 · see citing works

Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes

Nakatsu, G., Zhou, H., Wu, W. K. K., Wong, S. H., Coker, O. O., Dai, Z., Li, X., Szeto, C.-H., Sugimura, N., Lam, T. Y.-T., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.018 · Cited by 386 · see citing works

The role of gut microbiota in cancer treatment: friend or foe?

Cheng, W. Y., Wu, C.-Y., & Yu, J. (2020) · Gut · doi:10.1136/gutjnl-2020-321153 · Cited by 384 · see citing works

Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention

Hibberd, A. A., Lyra, A., Ouwehand, A. C., Rolny, P., Lindegren, H., Cedgård, L., & Wettergren, Y. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000145 · Cited by 373 · see citing works

Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential

Saus, E., Iraola‐Guzmán, S., Willis, J. R., Brunet‐Vega, A., & Gabaldón, T. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.05.001 · Cited by 348 · see citing works

A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer

Liang, Q., Li, T., Nakatsu, G., Chen, Y., Yau, T. O., Chu, E. S., Wong, S. H., Szeto, C. H., Ng, S. C., Chan, F. K. L., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318532 · Cited by 344 · see citing works

Fecal microbiota transplantation in cancer management: Current status and perspectives

Chen, D., Wu, J., Jin, D., Wang, B., & Cao, H. (2018) · International Journal of Cancer · doi:10.1002/ijc.32003 · Cited by 330 · see citing works

Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer

Qu, R., Zhang, Y., Ma, Y., Zhou, X., Sun, L., Jiang, C., Zhang, Z., & Fu, W. (2023) · Advanced Science · doi:10.1002/advs.202205563 · Cited by 303 · see citing works

Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer

Kwong, T. N. Y., Wang, X., Nakatsu, G., Chow, T. C., Tipoe, T., Dai, R. Z. W., Tsoi, K. K. K., Wong, M. C. S., Tse, G., Chan, M. T. V., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.028 · Cited by 280 · see citing works

A Framework for Effective Application of Machine Learning to Microbiome-Based Classification Problems

Topçuoğlu, B. D., Lesniak, N. A., Ruffin, M. T., Wiens, J., & Schloss, P. D. (2020) · mBio · doi:10.1128/mbio.00434-20 · Cited by 278 · see citing works

Increased Abundance of Clostridium and Fusobacterium in Gastric Microbiota of Patients with Gastric Cancer in Taiwan

Hsieh, Y.-Y., Tung, S.-Y., Pan, H.-Y., Yen, C.-W., Xu, H.-W., Lin, Y.-J., Deng, Y.-F., Hsu, W.-T., Wu, C.-S., & Li, C. (2018) · Scientific Reports · doi:10.1038/s41598-017-18596-0 · Cited by 269 · see citing works

Machine learning for microbiologists

Asnicar, F., Thomas, A. M., Passerini, A., Waldron, L., & Segata, N. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00984-1 · Cited by 269 · see citing works

<i>Fusobacterium nucleatum</i>and colorectal cancer: A review

Shang, F.-M., & Liu, H.-L. (2018) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v10.i3.71 · Cited by 258 · see citing works

Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers

Coker, O. O., Liu, C., Wu, W. K. K., Wong, S. H., Jia, W. P., Sung, J. J. �., & Yu, J. Q. (2022) · Microbiome · doi:10.1186/s40168-021-01208-5 · Cited by 259 · see citing works

Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism?

Ternes, D., Karta, J., Tsenkova, M., Wilmes, P., Haan, S., & Letellier, E. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.01.001 · Cited by 256 · see citing works

Novel Diagnostic Biomarkers in Colorectal Cancer

Zygulska, A. L., & Pierzchalski, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020852 · Cited by 253 · see citing works

Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS /KRT7

Chen, S., Su, T., Zhang, Y., Lee, A. A., He, J., Ge, Q., Wang, L., Si, J., Zhuo, W., & Wang, L. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1695494 · Cited by 232 · see citing works

Cancer‐associated fecal microbial markers in colorectal cancer detection

Eklöf, V., Löfgren‐Burström, A., Zingmark, C., Edin, S., Larsson, P. G., Karling, P., Alexeyev, O. A., Rutegård, M., Wikberg, M. L., & Palmqvist, R. (2017) · International Journal of Cancer · doi:10.1002/ijc.31011 · Cited by 209 · see citing works

Fusobacterium nucleatum and cancer

Alon‐Maimon, T., Mandelboim, O., & Bachrach, G. (2022) · Periodontology 2000 · doi:10.1111/prd.12426 · Cited by 200 · see citing works

Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies

Xie, Y., Gao, Q., Cai, G. X., Sun, X. M., Zou, T.-H., Chen, H. M., Yu, S.-Y., Qiu, Y.-W., Gu, W.-Q., Chen, X. Y., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.10.005 · Cited by 192 · see citing works

Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer

Osman, M. A., Neoh, H., Mutalib, N. A., Chin, S., Mazlan, L., Ali, R. A. R., Zakaria, A. D., Ngiu, C. S., Ang, M. Y., & Jamal, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-82465-0 · Cited by 185 · see citing works

Fusobacterium nucleatum aggravates rheumatoid arthritis through FadA-containing outer membrane vesicles

Hong, M., Li, Z., Liu, H., Zheng, S., Zhang, F., Zhu, J., Shi, H., Ye, H., Chou, Z., Gao, L., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.018 · Cited by 180 · see citing works

A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of Fusobacterium Nucleatum to Probiotics Populations, Based on Their Antagonistic Effect

Guo, S., Li, L., Xu, B., Mang-hui, L., Zeng, Q., Han, X., Ying, X., Wu, Y., Wang, Y., Liu, W., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.289728 · Cited by 171 · see citing works

Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities

Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 165 · see citing works

Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers

Sun, Y., Zhang, X., Hang, D., Lau, H. C.-H., Du, J., Liu, C., Xie, M., Pan, Y., Wang, L., Liang, C., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.07.005 · Cited by 164 · see citing works

<i>Fusobacterium nucleatum</i> and its associated systemic diseases: epidemiologic studies and possible mechanisms

Fan, Z., Tang, P., Li, C., Yang, Q., Xu, Y., Su, C., & Li, L. (2023) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2145729 · Cited by 150 · see citing works

Role of gut microbiota in the pathogenesis of colorectal cancer; a review article.

Sherafat, S. J., Alebouyeh, M., Moghim, S., Amoli, H. A., & Ghasemian-Safaei, H. (2018) · Gastroenterology and hepatology from bed to bench. · doi:10.22037/ghfbb.v0i0.1052 · Cited by 147 · see citing works

Bacteriophages and their potential for treatment of gastrointestinal diseases

Duan, Y., Young, R., & Schnabl, B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00536-z · Cited by 143 · see citing works

Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients

Zhao, L., Zhang, X., Zhou, Y., Fu, K., Lau, H. C.-H., Chun, T. W.-Y., Cheung, A. H. K., Coker, O. O., Wei, H., Wu, W. K. K., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02395-7 · Cited by 142 · see citing works

Microbial markers in colorectal cancer detection and/or prognosis

Villéger, R., Lopès, A., Véziant, J., Gagnière, J., Barnich, N., Billard, E., Boucher, D., & Bonnet, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i22.2327 · Cited by 139 · see citing works

Fusobacterium and Colorectal Cancer

Zhou, Z., Chen, J., Yao, H., & Hu, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00371 · Cited by 137 · see citing works

Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis

Gethings-Behncke, C., Coleman, H. G., Jordão, H. W. T., Longley, D. B., Crawford, N., Murray, L., & Kunzmann, A. T. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1295 · Cited by 137 · see citing works

Biomarkers for detecting colorectal cancer non-invasively: DNA, RNA or proteins?

Loktionov, A. S. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i2.124 · Cited by 129 · see citing works

Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality

Wang, S., Liu, Y., Li, J., Zhao, L., Yan, W., Lin, B., Guo, X., & Wei, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.710165 · Cited by 126 · see citing works

Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer

Lin, C., Cai, X., Zhang, J., Wang, W., Sheng, Q., Hua, H., & Zhou, X. (2018) · Digestion · doi:10.1159/000494052 · Cited by 121 · see citing works

Mucosa-associated microbiota signature in colorectal cancer

Gao, R., Kong, C., Huang, L., Li, H., Qu, X., Liu, Z., Lan, P., Wang, J., & Qin, H. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3026-4 · Cited by 120 · see citing works

Fecal Markers Streptococcus Anginosus and Streptococcus Constellatus for Non-Invasive Screening and Early Warning of Gastric Cancer

Zhou, C., Pan, S., Jin, P., Deng, J., Xue, J., Ma, X., Xie, Y., Cao, H., Liu, Q., Xie, W., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2022.02.015 · Cited by 116 · see citing works

Tumorigenic bacteria in colorectal cancer: mechanisms and treatments

Li, S., Liu, J., Zheng, X., Ren, L., Yang, Y., Li, W., Fu, W., Wang, J., & Du, G. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0651 · Cited by 115 · see citing works

Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients

Yan, X., Liu, L., Li, H., Qin, H., & Sun, Z. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s145949 · Cited by 110 · see citing works

Non-Invasive Colorectal Cancer Screening: An Overview

Tepus, M., & Yau, T. O. (2020) · Gastrointestinal Tumors · doi:10.1159/000507701 · Cited by 110 · see citing works

Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis

Niedermaier, T., Balavarca, Y., & Brenner, H. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000465 · Cited by 109 · see citing works

Clinical applications of gut microbiota in cancer biology

Wong, S. H., Kwong, T. N. Y., Wu, C., & Yu, J. Q. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.05.003 · Cited by 100 · see citing works

Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment

Liu, Y., Lau, H. C.-H., Cheng, W. Y., & Yu, J. Q. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.07.002 · Cited by 98 · see citing works

Oral microbiota affects the efficacy and prognosis of radiotherapy for colorectal cancer in mouse models

Dong, J., Li, Y., Xiao, H., Zhang, S., Wang, B., Wang, H., Li, Y., Fan, S., & Cui, M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109886 · Cited by 95 · see citing works

Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer

Löwenmark, T., Löfgren‐Burström, A., Zingmark, C., Eklöf, V., Dahlberg, M. L., Wai, S. N., Larsson, P. G., Ljuslinder, I., Edin, S., & Palmqvist, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-72132-1 · Cited by 94 · see citing works

Use of the synbiotic VSL#3 and yacon-based concentrate attenuates intestinal damage and reduces the abundance of Candidatus Saccharimonas in a colitis-associated carcinogenesis model

Cruz, B. C. D. S., da Conceição, L. L., Mendes, T. A. D. O., Ferreira, C. L. D. L. F., Gonçalves, R. V., & Pelúzio, M. D. C. G. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109721 · Cited by 92 · see citing works

The microbiome in cancer

Lin, A., Xiong, M., Jiang, A., Huang, L., Wong, H. Z. H., Feng, S., Zhang, C., Yu, H., Chen, L., Chi, H., et al. (2025) · iMeta · doi:10.1002/imt2.70070 · Cited by 91 · see citing works

Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression

Chang, Y., Huang, Z., Hou, F., Liu, Y., Wang, L., Wang, Z., Sun, Y., Pan, Z., Tan, Y., Ding, L., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02572-2 · Cited by 89 · see citing works

The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?

Smet, A., Kupčinskas, J., Link, A., Hold, G. L., & Bornschein, J. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.013 · Cited by 86 · see citing works

Advances in tests for colorectal cancer screening and diagnosis

Chan, S. C. H., & Liang, Q. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2065197 · Cited by 85 · see citing works

Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis

Huh, J., & Roh, T. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01887-4 · Cited by 78 · see citing works

Systematic evaluation of supervised classifiers for fecal microbiota-based prediction of colorectal cancer

Ai, L., Tian, H., Chen, Z., Chen, H., Xu, J., & Fang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14488 · Cited by 78 · see citing works

Multi-Omics Approaches in Colorectal Cancer Screening and Diagnosis, Recent Updates and Future Perspectives

Ullah, I., Yang, L., Yin, F., Sun, Y., Li, X., Li, J., & Wang, X. (2022) · Cancers · doi:10.3390/cancers14225545 · Cited by 76 · see citing works

An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine

Yamamoto, H., & Imai, K. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.08.003 · Cited by 74 · see citing works

From taxonomy to metabolic output: what factors define gut microbiome health?

Wilmanski, T., Rappaport, N., Diener, C., Gibbons, S. M., & Price, N. D. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907270 · Cited by 73 · see citing works

Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions

Zhang, S., Cai, S., & Ma, Y. (2018) · Journal of Cancer · doi:10.7150/jca.24048 · Cited by 73 · see citing works

Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families

Yang, J., Li, D., Yang, Z., Dai, W., Feng, X., Liu, Y., Jiang, Y., Li, P., Li, Y., Tang, B., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1712986 · Cited by 73 · see citing works

Fusobacterium’s link to colorectal neoplasia sequenced: A systematic review and future insights

Hussan, H., Clinton, S. K., Roberts, K., & Bailey, M. T. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i48.8626 · Cited by 73 · see citing works

A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition

Saber, S., El-Fattah, E. E. A., Yahya, G., Gobba, N. A., Maghmomeh, A. O., Khodir, A. E., Mourad, A. A. E., Saad, A. S., Mohammed, H. G., Nouh, N. A. T., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14040341 · Cited by 72 · see citing works

Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer

Véziant, J., Villéger, R., Barnich, N., & Bonnet, M. (2021) · Cancers · doi:10.3390/cancers13092215 · Cited by 72 · see citing works

Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation

Sun, J., Song, S., Liu, J., Chen, F., Li, X., & Wu, G. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00678-x · Cited by 72 · see citing works

Colorectal cancer-associated anaerobic bacteria proliferate in tumor spheroids and alter the microenvironment

Kasper, S. H., Morell-Perez, C., Wyche, T. P., Sana, T. R., Lieberman, L. A., & Hett, E. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-62139-z · Cited by 69 · see citing works

Role of gut microbiota in epigenetic regulation of colorectal Cancer

Zhao, Y., Wang, C., & Goel, A. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188490 · Cited by 68 · see citing works

Fusobacterium nucleatum: ecology, pathogenesis and clinical implications

Jiang, S., Chen, Y., & Fang, J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01237-z · Cited by 70 · see citing works

Sensitivity of Fecal Immunochemical Test for Colorectal Cancer Detection Differs According to Stage and Location

Niedermaier, T., Tikk, K., Gies, A., Bieck, S., & Brenner, H. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.01.025 · Cited by 67 · see citing works

Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta‐analysis

Zhang, X., Zhu, X., Cao, Y., Fang, J., Hong, J., & Chen, H. (2019) · Cancer Medicine · doi:10.1002/cam4.1850 · Cited by 63 · see citing works

Microbiota Profile and Impact of Fusobacterium nucleatum in Colorectal Cancer Patients of Barretos Cancer Hospital

de Carvalho, A. C., Pereira, L. D. M., Datorre, J. G., dos Santos, W., Berardinelli, G. N., Matsushita, M. D. M., de Oliveira, M. A., Durães, R. O., Guimarães, D. P., & Reis, R. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00813 · Cited by 63 · see citing works

The protective effect of Lactobacillus versus 5-aminosalicylic acid in ulcerative colitis model by modulation of gut microbiota and Nrf2/Ho-1 pathway

El-Baz, A. M., Khodir, A. E., El‐Sokkary, M. M. A., & Shata, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117927 · Cited by 63 · see citing works

Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon

Pu, L. Z. C. T., Yamamoto, K., Honda, T., Nakamura, M., Yamamura, T., Hattori, S., Burt, A. D., Singh, R., Hirooka, Y., & Fujishiro, M. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14868 · Cited by 61 · see citing works

Faecal microbial biomarkers in early diagnosis of colorectal cancer

Olovo, C. V., Huang, X., Zheng, X., & Xu, M. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17010 · Cited by 60 · see citing works

Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer

Lee, S. A., Liu, F., Riordan, S. M., Lee, C. S., & Zhang, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00566 · Cited by 59 · see citing works

Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences

Tortora, S. C., Bodiwala, V., Quinn, A., Martello, L. A., & Vignesh, S. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i2.375 · Cited by 58 · see citing works

Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy

Ganesan, K., Guo, S., Fayyaz, S., Zhang, G., & Xu, B. (2019) · Cancers · doi:10.3390/cancers11101592 · Cited by 58 · see citing works

Cancer-associated inflammation: pathophysiology and clinical significance

Pęczek, P., Gajda, M., Rutkowski, K., Fudalej, M. M., Deptała, A., & Badowska-Kozakiewicz, A. M. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04399-y · Cited by 56 · see citing works

Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets

Dai, J.-H., Tan, X.-R., Qiao, H., & Liu, N. (2023) · Protein & Cell · doi:10.1093/procel/pwad052 · Cited by 56 · see citing works

Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients

Tunsjø, H. S., Gundersen, G., Rangnes, F., Noone, J. C., Endres, A., & Bemanian, V. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03562-7 · Cited by 55 · see citing works

The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer

Liu, K., Yang, X., Zeng, M., Yuan, Y., Sun, J., He, P., Sun, J., Xie, Q., Chang, X., Zhang, S., et al. (2021) · Disease Markers · doi:10.1155/2021/1171239 · Cited by 54 · see citing works

Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions

Gao, R., Wang, Z., Li, H., Cao, Z., Gao, Z., Chen, H., Zhang, X., Pan, D., Yang, R., Zhong, H., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15077 · Cited by 50 · see citing works

Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis

Huang, X., Hong, X., Wang, J., Sun, T., Yu, T., Yu, Y., Fang, J., & Xiong, H. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103037 · Cited by 50 · see citing works

Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori -positive gastric cancer patients

Hsieh, Y., Tung, S., Pan, H.-Y., Chang, T., Wei, K., Chen, W., Deng, Y.-F., Lu, C.-K., Lai, Y., Wu, C., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i42.7311 · Cited by 50 · see citing works

Periodontitis increases the risk of gastrointestinal dysfunction: an update on the plausible pathogenic molecular mechanisms

Mukherjee, S., Chopra, A., Karmakar, S., & Bhat, G. S. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2339260 · Cited by 49 · see citing works

Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers

Fang, C., Chen, J., Hsu, B., Hussain, B., Rathod, J., & Lee, K. (2021) · Microorganisms · doi:10.3390/microorganisms9081548 · Cited by 47 · see citing works

The Fruits of Paris polyphylla Inhibit Colorectal Cancer Cell Migration Induced by Fusobacterium nucleatum-Derived Extracellular Vesicles

Lin, L., Shi, Y.-C., Choong, C.-Y., & Tai, C. (2021) · Molecules · doi:10.3390/molecules26134081 · Cited by 47 · see citing works

Emerging strategies for combating Fusobacterium nucleatum in colorectal cancer treatment: Systematic review, improvements and future challenges

Liu, H., Yu, Y., Dong, A., Elsabahy, M., Yang, Y., & Gao, H. (2023) · Exploration · doi:10.1002/exp.20230092 · Cited by 46 · see citing works

Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer

Liu, Y., Baba, Y., Ishimoto, T., Iwatsuki, M., Hiyoshi, Y., Miyamoto, Y., Yoshida, N., Wu, R., & Baba, H. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1512-9 · Cited by 47 · see citing works

The pathogenic oral–gut–liver axis: new understandings and clinical implications

Imai, J., Kitamoto, S., & Kamada, N. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1935877 · Cited by 45 · see citing works

The gastrointestinal microbiota and its role in oncogenesis

Lam, S. Y., Yu, J. Q., Wong, S. H., Peppelenbosch, M. P., & Fuhler, G. M. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.010 · Cited by 45 · see citing works

Role of the gut microbiota in tumorigenesis and treatment

Liu, Q., Yang, Y., Pan, M., Yang, F., Yu, Y., & Qian, Z. (2024) · Theranostics · doi:10.7150/thno.91700 · Cited by 43 · see citing works

Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population

Iadsee, N., Chuaypen, N., Techawiwattanaboon, T., Jinato, T., Patcharatrakul, T., Malakorn, S., Petchlorlian, A., Praditpornsilpa, K., & Patarakul, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-33794-9 · Cited by 42 · see citing works

Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma

Liao, Y., Zhang, J., Lu, L., Jia, Y., Zheng, M., Debelius, J. W., He, Y., Wang, T., Deng, C., Tong, X., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03448-22 · Cited by 41 · see citing works

Disruption of the intestinal clock drives dysbiosis and impaired barrier function in colorectal cancer

Fellows, R. C., Chun, S. K., Larson, N., Fortin, B. M., Mahieu, A. L., Song, W. A., Seldin, M. M., Pannunzio, N. R., & Masri, S. (2024) · Science Advances · doi:10.1126/sciadv.ado1458 · Cited by 41 · see citing works

The Gut Microbiome and Colorectal Cancer: An Integrative Review of the Underlying Mechanisms

Karam, F., Deghel, Y. E., Iratni, R., Dakroub, A. H., & Eid, A. H. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01683-9 · Cited by 41 · see citing works

Alteration of the abundance of Parvimonas micra in the gut along the adenoma‑carcinoma sequence

Xu, J., Yang, M. H., Wang, D., Zhang, S., Yan, S., Zhu, Y., & Chen, W. (2020) · Oncology Letters · doi:10.3892/ol.2020.11967 · Cited by 41 · see citing works

Fecal microbial DNA markers serve for screening colorectal neoplasm in asymptomatic subjects

Liang, Q., Wong, S. H., Szeto, C. H., Chu, E. S., Lau, H. C.-H., Chen, Y., Fang, J., Yu, J. Q., & Sung, J. J. �. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15171 · Cited by 57 · see citing works

A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer

Liang, Q., Li, T., Nakatsu, G., Chen, Y., Yau, T. O., Chu, E. S., Wong, S. H., Szeto, C. H., Ng, S. C., Chan, F. K. L., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318532 · Cited by 344 · see citing works

IDDF2026-ABS-0439 An asia pacific multicenter prospective study to compare the diagnostic accuracy of bacterial gene markers and fecal immunochemical test for advanced colorectal neoplasia

Dai, M., Lau, L. H.-S., Abdullah, M., Sugimura, N., Hirata, D., Sano, Y., Tan, C. K., Ang, T. L., Chang, W., Chiu, H., et al. (2026) · Gut · doi:10.1136/gutjnl-2026-iddf.347 · Cited by 1 · see citing works

DdPCR (droplet digital PCR) analysis of Fusobacterium nucleatum in FIT samples can potentially ameliorate colorectal cancer and advanced adenoma detection performance in a screening population

Guimarães, D. P., Datorre, J. G., dos Reis, M. B., Reis, M., de Carvalho, A. C., & Reis, R. M. (2023) · Endoscopy · doi:10.1055/s-0043-1765410

Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma

Zhang, Y., Lu, M., Lu, B., Liu, C., Ma, Y., Liu, L., Miao, X., Qin, J., Chen, H., & Dai, M. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000389 · Cited by 18 · see citing works